KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
8.36
+0.27 (3.34%)
At close: Dec 20, 2024, 4:00 PM
8.50
+0.14 (1.67%)
After-hours: Dec 20, 2024, 7:57 PM EST
KalVista Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Oct '24 Oct 31, 2024 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
| Revenue | - | - | - | - | - | 12.69 | |
| Revenue Growth (YoY) | - | - | - | - | - | -21.31% | |
| Cost of Revenue | 91 | 86.17 | 80.28 | 70.17 | 41.29 | 40.19 | |
| Gross Profit | -91 | -86.17 | -80.28 | -70.17 | -41.29 | -27.5 | |
| Selling, General & Admin | 80.64 | 54.28 | 30.6 | 26.45 | 16.64 | 13.03 | |
| Operating Expenses | 80.64 | 54.28 | 30.6 | 26.45 | 16.64 | 13.03 | |
| Operating Income | -171.63 | -140.45 | -110.87 | -96.61 | -57.92 | -40.53 | |
| Interest & Investment Income | 5.25 | 3.9 | 2.23 | 1.09 | 0.9 | 1.83 | |
| Currency Exchange Gain (Loss) | 1.56 | 0.14 | 0.09 | -1.54 | 0.85 | -0.37 | |
| Other Non Operating Income (Expenses) | 7.05 | 8.44 | 15.78 | 15.3 | 9.93 | 9.53 | |
| EBT Excluding Unusual Items | -157.77 | -127.97 | -92.77 | -81.76 | -46.24 | -29.54 | |
| Gain (Loss) on Sale of Investments | 1.38 | 1.33 | -0.14 | -0.58 | - | 0.3 | |
| Pretax Income | -156.39 | -126.64 | -92.91 | -82.34 | -46.24 | -29.24 | |
| Income Tax Expense | - | - | - | - | - | -0.12 | |
| Net Income | -156.39 | -126.64 | -92.91 | -82.34 | -46.24 | -29.12 | |
| Net Income to Common | -156.39 | -126.64 | -92.91 | -82.34 | -46.24 | -29.12 | |
| Shares Outstanding (Basic) | 43 | 37 | 28 | 24 | 19 | 18 | |
| Shares Outstanding (Diluted) | 43 | 37 | 28 | 24 | 19 | 18 | |
| Shares Change (YoY) | 30.22% | 31.89% | 13.97% | 28.17% | 7.58% | 17.69% | |
| EPS (Basic) | -3.66 | -3.44 | -3.33 | -3.36 | -2.42 | -1.64 | |
| EPS (Diluted) | -3.66 | -3.44 | -3.33 | -3.36 | -2.42 | -1.64 | |
| Free Cash Flow | -122.7 | -89.27 | -76.46 | -79.07 | -30.25 | -45.04 | |
| Free Cash Flow Per Share | -2.87 | -2.43 | -2.74 | -3.23 | -1.58 | -2.54 | |
| Gross Margin | - | - | - | - | - | -216.74% | |
| Operating Margin | - | - | - | - | - | -319.41% | |
| Profit Margin | - | - | - | - | - | -229.44% | |
| Free Cash Flow Margin | - | - | - | - | - | -354.89% | |
| EBITDA | -170.76 | -139.63 | -110.15 | -96.05 | -57.39 | -40.02 | |
| D&A For EBITDA | 0.88 | 0.82 | 0.72 | 0.56 | 0.54 | 0.51 | |
| EBIT | -171.63 | -140.45 | -110.87 | -96.61 | -57.92 | -40.53 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.